Liwen Lin

1.6k total citations
38 papers, 1.3k citations indexed

About

Liwen Lin is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Liwen Lin has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Liwen Lin's work include Immune Response and Inflammation (4 papers), Immunotherapy and Immune Responses (3 papers) and Magnetic properties of thin films (3 papers). Liwen Lin is often cited by papers focused on Immune Response and Inflammation (4 papers), Immunotherapy and Immune Responses (3 papers) and Magnetic properties of thin films (3 papers). Liwen Lin collaborates with scholars based in China, United States and Australia. Liwen Lin's co-authors include Yang Leng, King Lau Chow, Li Zhai, Xinyu Zhang, Chao Song, Todd V. Brennan, Yiping Yang, Keith Dredge, Lianming Zhang and Jinfang Nie and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Liwen Lin

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liwen Lin China 14 447 428 175 169 156 38 1.3k
Weimin Lin China 22 552 1.2× 536 1.3× 171 1.0× 135 0.8× 53 0.3× 127 1.7k
Yi‐Jane Chen Taiwan 34 913 2.0× 328 0.8× 170 1.0× 424 2.5× 167 1.1× 121 3.6k
Yu‐Chen Liu Taiwan 16 677 1.5× 416 1.0× 58 0.3× 99 0.6× 96 0.6× 61 1.6k
Hansang Lee South Korea 22 338 0.8× 343 0.8× 236 1.3× 71 0.4× 59 0.4× 81 1.6k
Xinyu Qiu China 18 553 1.2× 314 0.7× 76 0.4× 182 1.1× 42 0.3× 53 1.4k
Lei Jing China 20 355 0.8× 211 0.5× 124 0.7× 174 1.0× 41 0.3× 74 1.2k
Jean‐Marc Grégoire France 18 503 1.1× 275 0.6× 63 0.4× 114 0.7× 62 0.4× 45 1.3k
Seungmin Han South Korea 23 468 1.0× 357 0.8× 469 2.7× 158 0.9× 135 0.9× 72 1.6k
Zhixiong Zhang China 21 289 0.6× 364 0.9× 381 2.2× 47 0.3× 73 0.5× 121 1.5k
Shih‐Yao Chen Taiwan 23 538 1.2× 288 0.7× 150 0.9× 124 0.7× 45 0.3× 60 1.7k

Countries citing papers authored by Liwen Lin

Since Specialization
Citations

This map shows the geographic impact of Liwen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwen Lin more than expected).

Fields of papers citing papers by Liwen Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liwen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwen Lin. The network helps show where Liwen Lin may publish in the future.

Co-authorship network of co-authors of Liwen Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Liwen Lin. A scholar is included among the top collaborators of Liwen Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liwen Lin. Liwen Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Guang‐Hong, Weihong Wang, Baoyi Guan, et al.. (2025). Cycloastragenol reduces inflammation in CLP-induced septic MICE by suppressing TLR4 signaling pathways. Phytomedicine. 142. 156645–156645. 3 indexed citations
2.
Lin, Zhichao, Qing Miao, Liwen Lin, et al.. (2024). Mechanisms of QingRe HuoXue Formula in atherosclerosis Treatment: An integrated approach using Bioinformatics, Machine Learning, and experimental validation. International Immunopharmacology. 141. 112890–112890. 2 indexed citations
3.
Wang, Shushu, Liwen Lin, Yuxin Han, et al.. (2024). Exploring the mechanism of berberine treatment for atherosclerosis combined with non-alcoholic fatty liver disease based on bioinformatic and experimental study. PLoS ONE. 19(12). e0314961–e0314961. 2 indexed citations
4.
Wang, Chenxi, Zhichao Lin, Liwen Lin, et al.. (2024). Nao-Xin-Qing tablet inhibits macrophage inflammatory response in atherosclerosis via AMPK-α/SIRT1/PPAR-γ pathway. Journal of Traditional and Complementary Medicine. 15(5). 536–547.
5.
Lin, Liwen, Shushu Wang, Mingxin Dong, et al.. (2024). Huanglian Jiedu Decoction enhances the stability of atherosclerotic plaques through SLC2A1-mediated efferocytosis. International Immunopharmacology. 140. 112834–112834. 4 indexed citations
6.
Lin, Liwen, Honglin Xu, Yihua Li, et al.. (2024). Jin-Xin-Kang alleviates heart failure by mitigating mitochondrial dysfunction through the Calcineurin/Dynamin-Related Protein 1 signaling pathway. Journal of Ethnopharmacology. 335. 118685–118685. 10 indexed citations
7.
Wang, Shushu, Liwen Lin, Zhichao Lin, et al.. (2024). Screening for immune-related biomarkers associated with myasthenia gravis and dilated cardiomyopathy based on bioinformatics analysis and machine learning. Heliyon. 10(7). e28446–e28446. 4 indexed citations
9.
Samoylova, Mariya L., Tess C. Leuthner, Minghua Zhu, et al.. (2020). Effects of Immunosuppressive Medications on Mitochondrial Function. Journal of Surgical Research. 249. 50–57. 14 indexed citations
10.
Lin, Liwen, He Xu, Muath Bishawi, et al.. (2019). Circulating mitochondria in organ donors promote allograft rejection. American Journal of Transplantation. 19(7). 1917–1929. 61 indexed citations
11.
Hammond, Edward, Nicole M. Haynes, Carleen Cullinane, et al.. (2018). Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors. Journal for ImmunoTherapy of Cancer. 6(1). 54–54. 35 indexed citations
12.
13.
Dredge, Keith, Todd V. Brennan, Edward Hammond, et al.. (2018). A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours. British Journal of Cancer. 118(8). 1035–1041. 73 indexed citations
14.
Barbas, Andrew S., et al.. (2018). Heparan sulfate is a plasma biomarker of acute cellular allograft rejection. PLoS ONE. 13(8). e0200877–e0200877. 10 indexed citations
15.
Weinhold, Kent J., Jack F. Bukowski, Todd V. Brennan, et al.. (2018). Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers. Clinical Immunology. 191. 10–20. 26 indexed citations
16.
Li, Ru, et al.. (2016). Quantitative Protein Sulfenic Acid Analysis Identifies Platelet Releasate-Induced Activation of Integrin β2 on Monocytes via NADPH Oxidase. Journal of Proteome Research. 15(12). 4221–4233. 12 indexed citations
17.
Nie, Jinfang, Yun Zhang, Liwen Lin, et al.. (2012). Low-Cost Fabrication of Paper-Based Microfluidic Devices by One-Step Plotting. Analytical Chemistry. 84(15). 6331–6335. 187 indexed citations
19.
Lin, Liwen, King Lau Chow, & Yang Leng. (2008). Study of hydroxyapatite osteoinductivity with an osteogenic differentiation of mesenchymal stem cells. Journal of Biomedical Materials Research Part A. 89A(2). 326–335. 204 indexed citations
20.
Lin, Liwen, et al.. (2006). Short-circuiting effect on the magnetoresistance of microstructured permalloy rings. Journal of Magnetism and Magnetic Materials. 310(2). 1986–1988. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026